1. Regional diversity in the postsynaptic proteome of the mouse brain
- Author
-
Seth G. N. Grant, Colin Mclean, J. Douglas Armstrong, Marcia Roy, Javier DeFelipe, Oksana Sorokina, Silvia Tapia-González, European Commission, and University of Edinburgh
- Subjects
0301 basic medicine ,Proteome ,proteome ,Clinical Biochemistry ,lcsh:QR1-502 ,Hindbrain ,Computational biology ,Biochemistry ,Article ,postsynaptic ,lcsh:Microbiology ,Synapse ,03 medical and health sciences ,0302 clinical medicine ,Structural Biology ,Postsynaptic potential ,synapse ,biology.animal ,Connectome ,medicine ,Protein interaction networks ,protein interaction networks ,Molecular Biology ,030304 developmental biology ,mass spectrometry ,0303 health sciences ,Mass spectrometry ,biology ,connectome ,Vertebrate ,Human brain ,3. Good health ,030104 developmental biology ,medicine.anatomical_structure ,Forebrain ,Excitatory postsynaptic potential ,Postsynaptic ,030217 neurology & neurosurgery - Abstract
The proteome of the postsynaptic terminal of excitatory synapses comprises over one thousand proteins in vertebrate species and plays a central role in behavior and brain disease. The brain is organized into anatomically distinct regions and whether the synapse proteome differs across these regions is poorly understood. Postsynaptic proteomes were isolated from seven forebrain and hindbrain regions in mice and their composition determined using proteomic mass spectrometry. Seventy-four percent of proteins showed differential expression and each region displayed a unique compositional signature. These signatures correlated with the anatomical divisions of the brain and their embryological origins. Biochemical pathways controlling plasticity and disease, protein interaction networks and individual proteins involved with cognition all showed differential regional expression. Combining proteomic and connectomic data shows that interconnected regions have specific proteome signatures. Diversity in synapse proteome composition is key feature of mouse and human brain structure., Support was obtained from the Medical Research Council (G0802238), European Union Seventh Framework Programme (FP7 grant agreement No. 604102) and Horizon 2020 (grant agreement No. 72027). We thank T. Le Bihan and L. Imrie at SynthSys, University of Edinburgh, for mass spectrometry sample analysis. The LC-MS QExactive equipment was purchased by a Wellcome Trust Institutional Strategic Support Fund and a strategic award from the Wellcome Trust for the Centre for Immunity, Infection and Evolution (095831/Z/11/Z). Data were extracted from Neuroimaging Informatics Technology Initiative (NIFTI) files using a custom automated script written by J. Roy, MEMEX, Inc. (Burlington, Ontario, Canada). We thank K. Elsegood for laboratory management and D. Maizels for artwork; C.S. Davey, editing.
- Published
- 2018
- Full Text
- View/download PDF